Barceló et al. analyzed 400 different miRNAs from semen samples of patients with BPH, healthy controls, and patients with moderately elevated PSA levels and Gleason Score (GS) 6–8 in order to find a reliable biomarker for early diagnosis of prostate cancer [53]. Here, KLK3 is linked to benign prostatic hyperplasia.